Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway

Fig. 4

Regional incidence of Pneumocystis jirovecii detected by PCR in Central Norway. Estimated incidence rates of individuals resulting positive for P. jirovecii by PCR in Central Norway health region (dark columns) with 95% confidence intervals and resulting linear trend (dotted line). PCR was introduced in late 2006 in our regional referral laboratory. Thus, estimates were calculated from 2007. Molde hospital, a local hospital in the health region, established PCR detection for P. jirovecii too in 2017. For completeness, individuals resulting positive there were included in the regional incidence estimates for 2017 (*). Regional population counts from Statistic Norway were used to compute the incidence rates. PCR, polymerase chain reaction

Back to article page